Metastatic medullary thyroid carcinoma (MTC): disease course, treatment modalities and factors predisposing for drug resistance
Author:
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Link
https://link.springer.com/content/pdf/10.1007/s12020-022-03296-1.pdf
Reference34 articles.
1. M.E. Cabanillas, M. Ryder, C. Jimenez, Targeted therapy for advanced thyroid cancer: kinase inhibitors and beyond. Endocr. Rev. 40(6), 1573–1604 (2019)
2. R. Dadu, R. Bagheri-Yarmand, M.D. Ringel, E.G. Grubbs, M. Zafereo, G. Cote, R.F. Gagel, B.G. Robinson, K.R. Shaw, M.I. Hu, Hereditary endocrine tumours: Current state-of-the-art and research opportunities: The state of science in medullary thyroid carcinoma: current challenges and unmet needs. Endocr.-Relat. Cancer 27(8), T27–T39 (2020)
3. K. Saltiki, G. Simeakis, O. Karapanou, M. Alevizaki, Management of endocrine disease: Medullary thyroid cancer: from molecular biology and therapeutic pitfalls to future targeted treatment perspectives. Eur. J. Endocrinol. 187(3), R53–r63 (2022)
4. S.A. Wells Jr., S.L. Asa, H. Dralle, R. Elisei, D.B. Evans, R.F. Gagel, N. Lee, A. Machens, J.F. Moley, F. Pacini et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid.: Off. J. Am. Thyroid. Assoc. 25(6), 567–610 (2015)
5. M.E. Cabanillas, M.I. Hu, C. Jimenez, Medullary thyroid cancer in the era of tyrosine kinase inhibitors: to treat or not to treat–and with which drug–those are the questions. J. Clin. Endocrinol. Metab. 99(12), 4390–4396 (2014)
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cabozantinib;Reactions Weekly;2024-04-27
2. Use of Neoadjuvant Vandetanib in Aggressive Pediatric Medullary Thyroid Carcinoma;JCO Precision Oncology;2024-02
3. Molecular Basis and Natural History of Medullary Thyroid Cancer: It is (Almost) All in the RET;Cancers;2023-10-05
4. Evaluation of Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Systemic Immune–Inflammation Index (SII) as Potential Biomarkers in Patients with Sporadic Medullary Thyroid Cancer (MTC);Journal of Personalized Medicine;2023-06-05
5. Transcriptomic Analysis Reveals Dysregulation of the Mycobiome and Archaeome and Distinct Oncogenic Characteristics according to Subtype and Gender in Papillary Thyroid Carcinoma;International Journal of Molecular Sciences;2023-02-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3